Management & Board of Directors
Chandra J. Panchal, PhD.
Founder, Chairman, Chief Executive Officer and Chief Scientific Officer
Dr. Panchal founded Axcelon in 2001 and was a co-founder of Procyon Biopharma Inc., a publicly traded biotechnology company involved in development of wound healing, cancer therapeutic and diagnostic products, which listed on Alberta Stock Exchange in 1998, the TSX in 2000 and changed its name to Ambrilia BioPharma Inc.. He served as Procyon Biopharma Inc.’s Chairman, President and CEO and Ambrilia Biopharma Inc.’s Senior Executive Vice-President, Business Development, Licensing and Intellectual Property in charge of both out-licensing, in-licensing and M&A activities. He retired from Ambrilia Biopharma Inc. in February 2008. Since then, Dr. Panchal has served as a consultant in the biomedical industry and has been an investor in technology. Prior to founding Procyon Biopharma Inc., Dr. Panchal was a senior scientist/group leader supervising activities related to yeast genetics, fermentations and product development at John Labatt Ltd., a multinational food and beverage company. Dr. Panchal was a director of Procyon Biopharma Inc. from 1989 to 2006. Dr. Panchal is on the board of directors of four public companies and MaRS Innovation. Dr. Panchal has authored over 50 scientific papers and has edited a book entitled Yeast Strain Selection, published in 1990. Dr. Panchal has been an Adjunct Professor at the University of Western Ontario where he obtained his Ph.D. in biochemical engineering.
Dino Mili, CPA, CA,
President & Chief Operating Officer
Mr. Mili has more than 30 years experience in the industrial and renewable energy sectors and he has worked on projects representing investments of more than $450 million. Work experiences centred on development, acquisition, and project financing for energy sector and industrial projects. Mr. Mili worked with Enerkem, gasification technology waste-to-biofuel, Domtar Inc., a pulp and paper company, CHI Canada Inc., a subsidiary of Enel GreenPower, a world leader in the renewable energy sector as well as a consultant for a number of other start-up bioproducts companies . Mr. Mili is a CPA,CA, and worked for with PriceWaterhouseCoopers, a major international accounting firm, before moving to the private sector.
Wankei Wan, PhD.
Director of R&D, Chief Technology AdvisorDr. Wan is Director, Transgenic Spider Silk Research, AFMNet and Graduate Program in Biomedical Engineering, and a Full Professor in the Department of Chemical and Biochemical Engineering at The University of Western Ontario (UWO). He is the inventor of the patent for dissolving and casting bacterial cellulose as well as co-inventor on three other biocellulose related patent and patent applications (assigned to Axcelon). He is a chemistry graduate from the State University of New York at Buffalo, N.Y. and has had extensive industrial experience as a Senior Scientist for the Exxon Research and Engineering Company and Imperial Oil Limited. Dr. Wan is an inventor of several processes which are the subject of patents and patent applications and is the Chair of the Graduate Program in Biomedical Engineering at UWO. He has published extensively and has been a recipient of several peer-reviewed grants.
Chris Ho, M.E.Sc, P.Eng
Senior Technical Advisor
Mr. Ho over 35 years process engineering & project execution experience in industrial gas applications, chemical, waste water and water treatment, pulp & paper and fermentation industries. The last 26 years he spent at Praxair Canada with responsibilities from Senior Development Engineer to Business Development Professional with activities in the Canada, US and China. He has designed, built and started-up processes for major clients working on gas/liquid mixing, gas dissolution, CO2 pH control, and fermentation.